Erez Chimovits's Net Worth
-$15.5 Million
Who is Erez Chimovits?
Erez Chimovits does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Adicet Bio, Inc., BiomX Inc., LogicBio Therapeutics, Inc., and Novus Therapeutics, Inc..
SEC CIK
Erez Chimovits's CIK is 0001706399
Past Insider Trading and Trends
2019 was Erez Chimovits's most active year for acquiring shares with 12 total transactions. Erez Chimovits's most active month to acquire stocks was the month of November. 2018 was Erez Chimovits's most active year for disposing of shares, totalling 2 transactions. Erez Chimovits's most active month to dispose stocks was the month of September. 2021 saw Erez Chimovits paying a total of $6,816,537.00 for 524,349 shares, this is the most they've acquired in one year. In 2018 Erez Chimovits cashed out on 5,725,514 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
BiomX Inc. (PHGE) Snapshot price: $0.2197
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 15
| |||
Form 4
| +12.37% | 348K |
$0.25 | $85,260.00 | 3.16M |
Feb 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 25
| |||
Form 4
| +0.17% | 4K |
$8.90 | $35,615.00 | 2.31M |
Dec 18 - Dec 19
| |||
Form 4
| +0.38% | 8.8K |
$8.85 | $77,918.00 | 2.31M |
Dec 10 - Dec 11
| |||
Form 4
| +0.45% | 10.2K |
$8.40 | $85,646.00 | 2.3M |
Dec 5 - Dec 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Adicet Bio, Inc. (ACET) Snapshot price: $3.22
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +12.10% | 875K |
$2.09 | $1,828,750.00 | 8.11M |
Jun 27
| |||
Form 4
| +10.25% | 524.35K |
$13.00 | $6,816,537.00 | 5.64M |
Feb 12
| |||
Form 4
|
∞
| 1.2M |
—
|
—
| 1.2M |
Sep 15 - Sep 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
LogicBio Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +22.91% | 1.48M |
$6.00 | $8,888,892.00 | 7.95M |
Oct 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 19
| |||
Form 4
|
∞
| 3.49M |
$10.00 |
—
| 3.49M |
Oct 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Novus Therapeutics, Inc. (ELDN) Snapshot price: $1.755
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 11
| |||
Form 4
| +25.47% | 646.2K |
$3.10 | $2,003,232.40 | 3.18M |
May 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||